Tesla Recalls Model...
Health Care: Drugs
Wyeth (WYE: NYSE)
$50.39 0.35 | 0.70%
10/15/09 - 04:03 PM ET
Ownership Summary data is not available for WYE.
Portfolios with WYE
- Portfolio NameUser Type
- UserMy Simple
- ProHighfields Capital Management
- ContributorDavid Einhorn's Top Stock H...
- Userdoublehaul
- ContributorFast Money's Wall Street Wh...
- ContributorCramer's Ways To Play Soft ...
- ContributorHealth Stock Winners & ...
- UserRichnTerri
- UserGlaxoSmithKline Strategic M...
- UserUndervalued Biotech's
Latest WYE Headlines from TheStreet
- SAC to Pay Record Insider Trading Penalty 03.16.13 | 11:03 am
- Business Highlights 08.03.10 | 06:08 pm
- FDA To Review First Of 3 New Weight Loss Drugs 07.12.10 | 12:07 am
- J&J Sales Plunge As New Drug Recall Announced 07.08.10 | 03:07 pm
- Archer Daniels Midland, Pfizer Are Active Movers 05.04.10 | 05:05 pm
- CEOs Focus on Growth in 2010 12.31.09 | 06:12 am
- Pfizer Says FDA Is Still Reviewing Prevnar 13 12.30.09 | 05:12 pm
- Jackson, Cronkite Among Arts World Deaths In 2009 12.30.09 | 03:12 pm
- Jackson, Cronkite Among Arts World Deaths In 2009 12.30.09 | 03:12 pm
- Farewell: Nobel Winner, King Of Pop Left Us In '09 12.30.09 | 03:12 pm
Press Releases for WYE
Partner Headlines for WYE
- Investment Opportunities in Women's Health - Seeking Alpha 06.04.10 | 04:06 pm
- Largest U.S. Equity Hedge Funds Revealed - SeekingAlpha.com 04.07.10 | 02:04 am
- Generex Brouhaha: Big Pharma Is Actually Not So Smart - SeekingAlpha.com 03.28.10 | 07:03 am
- Merck in talks to buy Millipore for up to $6bn - Financial Times 02.28.10 | 10:02 pm
- Expiry of patents cost Pfizer - Financial Times 02.04.10 | 12:02 am
- Tough times ahead as the gloom lingers on - Financial Times 01.24.10 | 11:01 pm
